Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Carfilzomib in Refractory Renal Cell Carcinoma (RCC) [Phase 2]
Phase 2 clinical trial update for carfilzomib in refractory renal cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) [Phase 2]
Phase 2 trial update on sunitinib scheduling in metastatic renal cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) [Phase 3]
Phase 3 trial comparing tivozanib hydrochloride to sorafenib in refractory advanced renal cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma [NA]
Completed clinical trial investigating intraoperative folate-targeted fluorescence for renal cell carcinoma with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer [NA]
Clinical trial on vaccine therapy before surgery for localized kidney cancer was terminated; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating total-body irradiation and fludarabine phosphate followed by donor peripheral blood stem cell transpla…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating MK-3475 (pembrolizumab) in combination with INCB024360 in various selected cancers; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors [Phase 1, Phase 2]
A dose-escalation and cohort-expansion study evaluating anti-CD27 (Varlilumab) with anti-PD-1 (Nivolumab) in advanced refractory solid tumor…
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228 [Phase 2]
Phase 2 continuation trial evaluating tolerability and activity of FK228 in patients who completed prior FK228 study (completed).
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426) [Phase 3]
A Phase 3 study (MK-3475-426/KEYNOTE-426) evaluating pembrolizumab in combination with axitinib versus sunitinib monotherapy in renal cell c…
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma [Phase 3]
Phase 3 trial comparing tivozanib to sorafenib in advanced renal cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line
Clinical trial evaluating the impact of a call center on management of metastatic/advanced renal cell carcinoma patients treated with suniti…
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer [Phase 1]
Phase 1 study of AR-42 (pan-DAC inhibitor) with pazopanib in advanced renal cell carcinoma and soft tissue sarcoma was terminated; results p…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors [Phase 2]
A phase 2 clinical trial evaluating axitinib in metastatic renal cell carcinoma with favorable prognostic factors has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Testosterone in Metastatic Renal Cell Carcinoma Patients [Phase 2]
A Phase 2 clinical trial investigating testosterone in patients with metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: A Research Study for Patients With Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial in metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib
A completed clinical trial evaluating first-line sunitinib in metastatic renal cell carcinoma with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 trial investigating everolimus after pazopanib in metastatic or advanced renal cell carcinoma has been terminated; results posted in…
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: A Study for Participants With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial update for participants with metastatic renal cell carcinoma; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC) [Phase 1, Phase 2]
Phase 1/2 trial of ixazomib with pegylated IFN-alpha 2b in metastatic renal cell carcinoma was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating hydroxychloroquine with aldesleukin in metastatic renal cell carcinoma has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) [Phase 3]
Phase 3 trial KEYNOTE-679/ECHO-302 evaluating pembrolizumab plus epacadostat versus standard of care in metastatic renal cell carcinoma has …
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients [Phase 3]
Phase 3 trial evaluating adjuvant axitinib in high-risk renal cell carcinoma; study terminated with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma [Phase 4]
Phase 4 safety trial of nivolumab in advanced or metastatic renal cell carcinoma completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating decitabine in combination with oxaliplatin for metastatic renal cell carcinoma.